SCOPUS 정보 검색 플랫폼

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1829-1842

Evaluation of metabolism-mediated herb-drug interactions

(6) Na, Dong Hee a Ji, Hye Young b Park, Eun Ji a Kim, Myung Sun a Liu, Kwang Hyeon c Lee, Hye Suk b

a Kyungsung University (South Korea)

b The Catholic University of Korea (South Korea)

c Kyungpook National University (South Korea)

Author keywords

Cytochrome P450; Herb drug interactions; In vitro methods; UDP glucuronosyltransferases

Indexed keywords

ALPRAZOLAM; AROMATIC HYDROCARBON RECEPTOR; BAICALIN; CYCLOSPORIN; CYTOCHROME P450; DIGOXIN; FEXOFENADINE; FLUCONAZOLE; GINKGO BILOBA EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RD; GLUCURONOSYLTRANSFERASE; GLYCOPROTEIN P; GYPENOSIDE; HYPERICUM PERFORATUM EXTRACT; IMATINIB; INDINAVIR; IRINOTECAN; LOPINAVIR; MIDAZOLAM; NIFEDIPINE; PREGNANE X RECEPTOR; SAQUINAVIR; TACROLIMUS; TOLBUTAMIDE; WARFARIN; ZIDOVUDINE;

DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE; GINKGO BILOBA; GLUCURONIDATION; HERB DRUG INTERACTION; HUMAN; HYPERICUM PERFORATUM; IN VITRO STUDY; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; LUMINESCENCE; MASS SPECTROMETRY; NONHUMAN; PHARMACOGENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SILYBUM MARIANUM; SINGLE DRUG DOSE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; DRUG EVALUATION, PRECLINICAL; ENZYME INDUCTION; ENZYME INHIBITORS; GLUCURONOSYLTRANSFERASE; HERB-DRUG INTERACTIONS; HUMANS; INTESTINES; LIVER; PHARMACOKINETICS; PLANT PREPARATIONS; RECOMBINANT PROTEINS;

EID: 83655197422 PISSN: 02536269 EISSN: 19763786 Source Type: Journal
DOI: 10.1007/s12272-011-1105-0 Document Type: Review

Times cited : (82)

References (104)

1
- 77950842156
- An update on drug interactions with the herbal medicine Ginkgo biloba
- 20359286 1:CAS:528:DC%2BC3cXmvFaitr8%3D 10.2174/138920010791110818
- M. J. Abad L. M. Bedoya P. Bermejo 2010 An update on drug interactions with the herbal medicine Ginkgo biloba Curr. Drug Metab. 11 171 181 20359286 1:CAS:528:DC%2BC3cXmvFaitr8%3D 10.2174/138920010791110818
- (2010) Curr. Drug Metab. , vol.11 , pp. 171-181
- Abad, M.J.¹ Bedoya, L.M.² Bermejo, P.³

2
- 4744350031
- Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage
- 15453681 1:CAS:528:DC%2BD2cXntFCqtbw%3D 10.1021/jf0490596
- C. Y. Ang L. Hu T. M. Heinze Y. Cui J. P. Freeman K. Kozak W. Luo F. F. Liu A. Mattia M. DiNovi 2004 Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage J. Agric. Food Chem. 52 6156 6164 15453681 1:CAS:528: DC%2BD2cXntFCqtbw%3D 10.1021/jf0490596
- (2004) J. Agric. Food Chem. , vol.52 , pp. 6156-6164
- Ang, C.Y.¹ Hu, L.² Heinze, T.M.³ Cui, Y.⁴ Freeman, J.P.⁵ Kozak, K.⁶ Luo, W.⁷ Liu, F.F.⁸ Mattia, A.⁹ Dinovi, M.¹⁰

3
- 76749107104
- Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells
- 20019244 10.1124/dmd.109.030197 1:CAS:528:DC%2BC3cXjt1OrtLg%3D
- S. Anthérieu C. Chesné R. Li S. Camus A. Lahoz L. Picazo M. Turpeinen A. Tolonen J. Uusitalo C. Guguen-Guillouzo A. Guillouzo 2010 Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells Drug Metab. Dispos. 38 516 525 20019244 10.1124/dmd.109.030197 1:CAS:528:DC%2BC3cXjt1OrtLg%3D
- (2010) Drug Metab. Dispos. , vol.38 , pp. 516-525
- Anthérieu, S.¹ Chesné, C.² Li, R.³ Camus, S.⁴ Lahoz, A.⁵ Picazo, L.⁶ Turpeinen, M.⁷ Tolonen, A.⁸ Uusitalo, J.⁹ Guguen-Guillouzo, C.¹⁰ Guillouzo, A.¹¹

4
- 34248147668
- Use of herbs among adults based on evidence-based indications: Findings from the National Health Interview Survey
- A. Bardia N. L. Nisly M. B. Zimmerman B. M. Gryzlak R. B. Wallace 2007 Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey Mayo Clin. Proc. 82 561 566 17493422 10.4065/82.5.561 (Pubitemid 46709424)
- (2007) Mayo Clinic Proceedings , vol.82 , Issue.5 , pp. 561-566
- Bardia, A.¹ Nisly, N.L.² Zimmerman, M.B.³ Gryzlak, B.M.⁴ Wallace, R.B.⁵

5
- 0033836868
- Drug interaction between St. John's wort and cyclosporine
- G. W. Barone B. J. Gurley B. L. Ketel M. L. Lightfoot S. R. Abul-Ezz 2000 Drug interaction between St. John's wort and cyclosporine Ann. Pharmacother. 34 1013 1016 10981246 1:STN:280:DC%2BD3M%2FmsVOltg%3D%3D 10.1345/aph.10088 (Pubitemid 30660777)
- (2000) Annals of Pharmacotherapy , vol.34 , Issue.9 , pp. 1013-1016
- Barone, G.W.¹ Gurley, B.J.² Ketel, B.L.³ Lightfoot, M.L.⁴ Abul-Ezz, S.R.⁵

6
- 43949115541
- Herbal medicine in the United States: Review of efficacy, safety, and regulation: Grand rounds at University of California, San Francisco Medical Center
- 18415652 10.1007/s11606-008-0632-y
- S. Bent 2008 Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center J. Gen. Intern. Med. 23 854 859 18415652 10.1007/s11606-008-0632- y
- (2008) J. Gen. Intern. Med. , vol.23 , pp. 854-859
- Bent, S.¹

7
- 10744232330
- The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
- DOI 10.1124/dmd.31.7.815
- T. D. Bjornsson J. T. Callaghan H. J. Einolf V. Fischer L. Gan S. Grimm J. Kao S. P. King G. Miwa L. Ni G. Kumar J. McLeod R. S. Obach S. Roberts A. Roe A. Shah F. Snikeris J. T. Sullivan D. Tweedie J. M. Vega J. Walsh S. A. Wrighton 2003 The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective Drug Metab. Dispos. 31 815 832 12814957 1:CAS:528:DC%2BD3sXltFalu70%3D 10.1124/dmd.31.7.815 (Pubitemid 36759050)
- (2003) Drug Metabolism and Disposition , vol.31 , Issue.7 , pp. 815-832
- Bjornsson, T.D.¹ Callaghan, J.T.² Einolf, H.J.³ Fischer, V.⁴ Gan, L.⁵ Grimm, S.⁶ Kao, J.⁷ King, S.P.⁸ Miwa, G.⁹ Ni, L.¹⁰ Kumar, G.¹¹ McLeod, J.¹² Obach, R.S.¹³ Roberts, S.¹⁴ Roe, A.¹⁵ Shah, A.¹⁶ Snikeris, F.¹⁷ Sullivan, J.T.¹⁸ Tweedie, D.¹⁹ Vega, J.M.²⁰ Walsh, J.²¹ Wrighton, S.A.²² more..

8
- 0037181419
- Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort [3]
- R. Bolley C. Zülke M. Kammerl M. Fischereder B. K. Krämer 2002 Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort Transplantation 73 1009 11923712 10.1097/00007890-200203270- 00035 (Pubitemid 34252375)
- (2002) Transplantation , vol.73 , Issue.6 , pp. 1009
- Bolley, R.¹ Zulke, C.² Kammerl, M.³ Fischereder, M.⁴ Kramer, B.K.⁵

9
- 0035015324
- High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1
- DOI 10.1002/rcm.290
- H. Z. Bu L. Magis K. Knuth P. Teitelbaum 2001 Highthroughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1 Rapid Commun. Mass Spectrom. 15 741 748 11344532 1:CAS:528:DC%2BD3MXktFOru7g%3D 10.1002/rcm.290 (Pubitemid 32479834)
- (2001) Rapid Communications in Mass Spectrometry , vol.15 , Issue.10 , pp. 741-748
- Bu, H.-Z.¹ Magis, L.² Knuth, K.³ Teitelbaum, P.⁴

10
- 30144432574
- Substrate specificity of human hepatic Udp-glucuronosyltransferases
- DOI 10.1016/S0076-6879(05)00003-0, PII S0076687905000030, 3, Phase II Conjugation Enzymes and Transport Systems
- B. Burchell D. J. Lockley A. Staines Y. Uesawa M. W. Coughtrie 2005 Substrate specificity of human hepatic UDP-glucuronosyltransferases Methods Enzymol. 400 46 57 16399342 1:CAS:528:DC%2BD28XoslCjsLo%3D 10.1016/S0076- 6879(05)00003-0 (Pubitemid 43052414)
- (2005) Methods in Enzymology , vol.400 , pp. 46-57
- Burchell, B.¹ Lockley, D.J.² Staines, A.³ Uesawa, Y.⁴ Coughtrie, M.W.H.⁵

11
- 33646131391
- Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: Identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1
- 16226778 1:CAS:528:DC%2BD28XktVGitbg%3D 10.1016/j.taap.2005.09.007
- T. K. Chang J. Chen E. Y. Yeung 2006 Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1 Toxicol. Appl. Pharmacol. 213 18 26 16226778 1:CAS:528:DC%2BD28XktVGitbg%3D 10.1016/j.taap.2005.09.007
- (2006) Toxicol. Appl. Pharmacol. , vol.213 , pp. 18-26
- Chang, T.K.¹ Chen, J.² Yeung, E.Y.³

12
- 48349090750
- Comparative analysis on microbial and rat metabolism of ginsenoside Rb1 by highperformance liquid chromatography coupled with tandem mass spectrometry
- 18384066 1:CAS:528:DC%2BD1cXptVegs70%3D 10.1002/bmc.1001
- G. Chen M. Yang Y. Song Z. Lu J. Zhang H. Huang S. Guan L. Wu D. A. Guo 2008 Comparative analysis on microbial and rat metabolism of ginsenoside Rb1 by highperformance liquid chromatography coupled with tandem mass spectrometry Biomed. Chromatogr. 22 779 785 18384066 1:CAS:528:DC%2BD1cXptVegs70%3D 10.1002/bmc.1001
- (2008) Biomed. Chromatogr. , vol.22 , pp. 779-785
- Chen, G.¹ Yang, M.² Song, Y.³ Lu, Z.⁴ Zhang, J.⁵ Huang, H.⁶ Guan, S.⁷ Wu, L.⁸ Guo, D.A.⁹

13
- 77954144994
- Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment
- 20399862 1:CAS:528:DC%2BC3cXosVWmsrw%3D 10.1016/j.phrs.2010.04.001
- C. Colalto 2010 Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment Pharmacol. Res. 62 207 227 20399862 1:CAS:528:DC%2BC3cXosVWmsrw%3D 10.1016/j.phrs.2010.04.001
- (2010) Pharmacol. Res. , vol.62 , pp. 207-227
- Colalto, C.¹

14
- 30144436526
- Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases
- DOI 10.1016/S0076-6879(05)00007-8, PII S0076687905000078, 7, Phase II Conjugation Enzymes and Transport Systems
- M. H. Court 2005 Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases Methods Enzymol. 400 104 116 16399346 1:CAS:528:DC%2BD28XoslCjsb8%3D 10.1016/S0076-6879(05)00007-8 (Pubitemid 43052418)
- (2005) Methods in Enzymology , vol.400 , pp. 104-116
- Court, M.H.¹

15
- 0035157254
- A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry
- E. A. Dierks K. R. Stams H. K. Lim G. Cornelius H. Zhang S. E. Ball 2001 A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry Drug Metab. Dispos. 29 23 29 11124225 1:CAS:528:DC%2BD3MXpvFGq (Pubitemid 32041675)
- (2001) Drug Metabolism and Disposition , vol.29 , Issue.1 , pp. 23-29
- Dierks, E.A.¹ Stams, K.R.² Lim, H.-K.³ Cornelius, G.⁴ Zhang, H.⁵ Ball, S.E.⁶

16
- 77951296034
- Validated assay for studying activity profiles of human liver UGTs after drug exposure: Inhibition and induction studies
- 20145913 1:CAS:528:DC%2BC3cXhslCmsrw%3D 10.1007/s00216-009-3441-1
- M. T. Donato S. Montero J. V. Castell M. J. Gómez-Lechón A. Lahoz 2010 Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies Anal. Bioanal. Chem. 396 2251 2263 20145913 1:CAS:528:DC%2BC3cXhslCmsrw%3D 10.1007/s00216-009-3441-1
- (2010) Anal. Bioanal. Chem. , vol.396 , pp. 2251-2263
- Donato, M.T.¹ Montero, S.² Castell, J.V.³ Gómez-Lechón, M.J.⁴ Lahoz, A.⁵

17
- 34547730805
- An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents
- DOI 10.1055/s-2007-981550
- A. S. Etheridge S. R. Black P. R. Patel J. So J. M. Mathews 2007 An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents Planta Med. 73 731 741 17611934 1:CAS:528: DC%2BD2sXoslSit7k%3D 10.1055/s-2007-981550 (Pubitemid 47234614)
- (2007) Planta Medica , vol.73 , Issue.8 , pp. 731-741
- Etheridge, A.S.¹ Black, S.R.² Patel, P.R.³ So, J.⁴ Mathews, J.M.⁵

18
- 65749091812
- Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers
- 19401473 1:CAS:528:DC%2BD1MXmsVelurg%3D 10.1345/aph.1L656
- L. Fan G. Y. Tao G. Wang Y. Chen W. Zhang Y. J. He Q. Li H. P. Lei F. Jiang D. L. Hu Y. F. Huang H. H. Zhou 2009 Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers Ann. Pharmacother. 43 944 949 19401473 1:CAS:528:DC%2BD1MXmsVelurg%3D 10.1345/aph.1L656
- (2009) Ann. Pharmacother. , vol.43 , pp. 944-949
- Fan, L.¹ Tao, G.Y.² Wang, G.³ Chen, Y.⁴ Zhang, W.⁵ He, Y.J.⁶ Li, Q.⁷ Lei, H.P.⁸ Jiang, F.⁹ Hu, D.L.¹⁰ Huang, Y.F.¹¹ Zhou, H.H.¹²

19
- 34247178491
- FDA, Guidance for Industry Available at:
- FDA, Guidance for Industry: Drug interaction studies-study design, data analysis and implications for dosing and labeling (2006). Available at: http://www.fda.gov/cder/guidance/index.htm.
- (2006) Drug Interaction Studies-study Design, Data Analysis and Implications for Dosing and Labeling

20
- 38749138848
- Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates
- DOI 10.1124/dmd.107.018705
- R. Fujiwara M. Nakajima H. Yamanaka M. Katoh T. Yokoi 2008 Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates Drug Metab. Dispos. 36 361 367 17998297 1:CAS:528:DC%2BD1cXht1yku74%3D 10.1124/dmd.107.018705 (Pubitemid 351185749)
- (2008) Drug Metabolism and Disposition , vol.36 , Issue.2 , pp. 361-367
- Fujiwara, R.¹ Nakajima, M.² Yamanaka, H.³ Katoh, M.⁴ Yokoi, T.⁵

21
- 0347917012
- Review about Ginkgo biloba special extract EGb 761 (Ginkgo)
- DOI 10.2174/1381612043386437
- H. J. Gertz M. Kiefer 2004 Review about Ginkgo biloba special extract EGb 761 (Ginkgo) Curr. Pharm. Des. 10 261 264 14754386 1:CAS:528: DC%2BD2cXmsVyntg%3D%3D 10.2174/1381612043386437 (Pubitemid 38072762)
- (2004) Current Pharmaceutical Design , vol.10 , Issue.3 , pp. 261-264
- Gertz, H.-J.¹ Kiefer, M.²

22
- 79851493460
- The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approaches
- 21208171 1:CAS:528:DC%2BC3MXisFKqurg%3D 10.2174/138920010794479637
- K. Grime D. D. Ferguson R. J. Riley 2010 The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approaches Curr. Drug Metab. 11 870 885 21208171 1:CAS:528:DC%2BC3MXisFKqurg%3D 10.2174/138920010794479637
- (2010) Curr. Drug Metab. , vol.11 , pp. 870-885
- Grime, K.¹ Ferguson, D.D.² Riley, R.J.³

23
- 67649389519
- The conduct of in vitro studies to address time-dependent inhibition of drugmetabolizing enzymes: A perspective of the pharmaceutical research and manufacturers of America
- 19359406 1:CAS:528:DC%2BD1MXosFenu7o%3D 10.1124/dmd.109.026716
- S. W. Grimm H. J. Einolf S. D. Hall K. He H. K. Lim K. H. Ling C. Lu A. A. Nomeir E. Seibert K. W. Skordos G. R. Tonn R. Van Horn R. W. Wang Y. N. Wong T. J. Yang R. S. Obach 2009 The conduct of in vitro studies to address time-dependent inhibition of drugmetabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America Drug Metab. Dispos. 37 1355 1370 19359406 1:CAS:528:DC%2BD1MXosFenu7o%3D 10.1124/dmd.109.026716
- (2009) Drug Metab. Dispos. , vol.37 , pp. 1355-1370
- Grimm, S.W.¹ Einolf, H.J.² Hall, S.D.³ He, K.⁴ Lim, H.K.⁵ Ling, K.H.⁶ Lu, C.⁷ Nomeir, A.A.⁸ Seibert, E.⁹ Skordos, K.W.¹⁰ Tonn, G.R.¹¹ Van Horn, R.¹² Wang, R.W.¹³ Wong, Y.N.¹⁴ Yang, T.J.¹⁵ Obach, R.S.¹⁶

24
- 33645050104
- Cytochrome P450s and other enzymes in drug metabolism and toxicity
- 16584116 1:CAS:528:DC%2BD28Xks1Kks70%3D 10.1208/aapsj080112
- F. P. Guengerich 2006 Cytochrome P450s and other enzymes in drug metabolism and toxicity AAPS J. 8 E101 E111 16584116 1:CAS:528: DC%2BD28Xks1Kks70%3D 10.1208/aapsj080112
- (2006) AAPS J. , vol.8
- Guengerich, F.P.¹

25
- 0037819284
- Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
- DOI 10.1038/sj.tpj.6500171
- C. Guillemette 2003 Pharmacogenomics of human UDP-glucuronosyltransferase enzymes Pharmacogenomics J. 3 136 158 12815363 1:CAS:528:DC%2BD3sXks1Cnu7w%3D 10.1038/sj.tpj.6500171 (Pubitemid 36850156)
- (2003) Pharmacogenomics Journal , vol.3 , Issue.3 , pp. 136-158
- Guillemette, C.¹

26
- 74549134800
- UGT genomic diversity: Beyond gene duplication
- 19857043 1:CAS:528:DC%2BC3cXlvFansQ%3D%3D 10.3109/03602530903210682
- C. Guillemette E. Lévesque M. Harvey J. Bellemare V. Menard 2010 UGT genomic diversity: beyond gene duplication Drug Metab. Rev. 42 24 44 19857043 1:CAS:528:DC%2BC3cXlvFansQ%3D%3D 10.3109/03602530903210682
- (2010) Drug Metab. Rev. , vol.42 , pp. 24-44
- Guillemette, C.¹ Lévesque, E.² Harvey, M.³ Bellemare, J.⁴ Menard, V.⁵

27
- 0036736521
- Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans
- 12235448 1:CAS:528:DC%2BD38XotVSmurw%3D 10.1067/mcp.2002.126913
- B. J. Gurley S. F. Gardner M. A. Hubbard D. K. Williams W. B. Gentry Y. Cui C. Y. Ang 2002 Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans Clin. Pharmacol. Ther. 72 276 287 12235448 1:CAS:528:DC%2BD38XotVSmurw%3D 10.1067/mcp.2002.126913
- (2002) Clin. Pharmacol. Ther. , vol.72 , pp. 276-287
- Gurley, B.J.¹ Gardner, S.F.² Hubbard, M.A.³ Williams, D.K.⁴ Gentry, W.B.⁵ Cui, Y.⁶ Ang, C.Y.⁷

28
- 33746043341
- Hypericum perforatum: Which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
- DOI 10.1055/s-2006-931585
- H. Gutmann B. Poller K. B. Büter A. Pfrunder W. Schaffner J. Drewe 2006 Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression? Planta Med. 72 685 690 16755466 1:CAS:528: DC%2BD28Xpt1Shtr8%3D 10.1055/s-2006-931585 (Pubitemid 44073450)
- (2006) Planta Medica , vol.72 , Issue.8 , pp. 685-690
- Gutmann, H.¹ Poller, B.² Buter, K.B.³ Pfrunder, A.⁴ Schaffner, W.⁵ Drewe, J.⁶

29
- 77952300660
- A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues
- 20228232 1:CAS:528:DC%2BC3cXmvVCjtLw%3D 10.1124/dmd.109.031831
- S. N. Hart Y. Li K. Nakamoto E. A. Subileau D. Steen X. B. Zhong 2010 A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues Drug Metab. Dispos. 38 988 994 20228232 1:CAS:528:DC%2BC3cXmvVCjtLw%3D 10.1124/dmd.109.031831
- (2010) Drug Metab. Dispos. , vol.38 , pp. 988-994
- Hart, S.N.¹ Li, Y.² Nakamoto, K.³ Subileau, E.A.⁴ Steen, D.⁵ Zhong, X.B.⁶

30
- 33847360957
- Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: Application to high-throughput inhibition screening of terpenoids
- DOI 10.1002/rcm.2881
- F. He H. C. Bi Z. Y. Xie Z. Zuo J. K. Li X. Li L. Z. Zhao X. Chen M. Huang 2007 Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/ mass spectrometry: application to high-throughput inhibition screening of terpenoids Rapid Commun. Mass Spectrom. 21 635 643 17279482 1:CAS:528:DC%2BD2sXis12hsrs%3D 10.1002/rcm.2881 (Pubitemid 46340306)
- (2007) Rapid Communications in Mass Spectrometry , vol.21 , Issue.5 , pp. 635-643
- He, F.¹ Bi, H.-C.² Xie, Z.-Y.³ Zuo, Z.⁴ Li, J.-K.⁵ Li, X.⁶ Zhao, L.-Z.⁷ Chen, X.⁸ Huang, M.⁹

31
- 78751553732
- Disposition pathways and pharmacokinetics of herbal medicines in humans
- 20939821 1:CAS:528:DC%2BC3MXis1WitQ%3D%3D 10.2174/092986710793205336
- S. M. He C. G. Li J. P. Liu E. Chan W. Duan S. F. Zhou 2010 Disposition pathways and pharmacokinetics of herbal medicines in humans Curr. Med. Chem. 17 4072 4113 20939821 1:CAS:528:DC%2BC3MXis1WitQ%3D%3D 10.2174/092986710793205336
- (2010) Curr. Med. Chem. , vol.17 , pp. 4072-4113
- He, S.M.¹ Li, C.G.² Liu, J.P.³ Chan, E.⁴ Duan, W.⁵ Zhou, S.F.⁶

32
- 79958290393
- ADME properties of herbal medicines in humans: Evidence, challenges and strategies
- 21385154 1:CAS:528:DC%2BC3MXlsVKlsbg%3D 10.2174/138161211795164194
- S. M. He E. Chan S. F. Zhou 2011 ADME properties of herbal medicines in humans: evidence, challenges and strategies Curr. Pharm. Des. 17 357 407 21385154 1:CAS:528:DC%2BC3MXlsVKlsbg%3D 10.2174/138161211795164194
- (2011) Curr. Pharm. Des. , vol.17 , pp. 357-407
- He, S.M.¹ Chan, E.² Zhou, S.F.³

33
- 42149119034
- In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products
- DOI 10.1111/j.1742-7843.2008.00227.x
- B. H. Hellum O. G. Nilsen 2008 In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products Basic Clin. Pharmacol. Toxicol. 102 466 475 18331390 1:CAS:528:DC%2BD1cXmtVWgsLs%3D 10.1111/j.1742-7843.2008.00227.x (Pubitemid 351537792)
- (2008) Basic and Clinical Pharmacology and Toxicology , vol.102 , Issue.5 , pp. 466-475
- Hellum, B.H.¹ Nilsen, O.G.²

34
- 35648976075
- Induction of hepatic cytochrome P450 enzymes: Methods, mechanisms, recommendations, and in vitro-in vivo correlations
- DOI 10.1080/00498250701534893, PII 783596675, Modelling and Simulation Approaches to in vitro-in vivo, Extrapolation of ADME Properties in Drug Development, Editor: Gordon Gibson, Guest Editor: Amin Rostami-Hodjegan
- N. J. Hewitt E. L. Lecluyse S. S. Ferguson 2007 Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations Xenobiotica 37 1196 1224 17968743 1:CAS:528:DC%2BD2sXht1ahu7vL 10.1080/00498250701534893 (Pubitemid 350035534)
- (2007) Xenobiotica , vol.37 , Issue.10-11 , pp. 1196-1224
- Hewitt, N.J.¹ Lecluyse, E.L.² Ferguson, S.S.³

35
- 34548065533
- Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases
- DOI 10.1002/mnfr.200600283
- S. I. Hoehle E. Pfeiffer M. Metzler 2007 Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases Mol. Nutr. Food Res. 51 932 938 17628876 1:CAS:528:DC%2BD2sXhtVSgtLfM 10.1002/mnfr.200600283 (Pubitemid 47292266)
- (2007) Molecular Nutrition and Food Research , vol.51 , Issue.8 , pp. 932-938
- Hoehle, S.I.¹ Pfeiffer, E.² Metzler, M.³

36
- 33846577441
- Drug interaction studies: Study design, data analysis, and implications for dosing and labeling
- DOI 10.1038/sj.clpt.6100054, PII 6100054
- S. M. Huang R. Temple D. C. Throckmorton L. J. Lesko 2007 Drug interaction studies: study design, data analysis, and implications for dosing and labeling Clin. Pharmacol. Ther. 81 298 304 17259955 1:CAS:528: DC%2BD2sXisFyrur4%3D 10.1038/sj.clpt.6100054 (Pubitemid 46174829)
- (2007) Clinical Pharmacology and Therapeutics , vol.81 , Issue.2 , pp. 298-304
- Huang, S.-M.¹ Temple, R.² Throckmorton, D.C.³ Lesko, L.J.⁴

37
- 44049087422
- Drug interactions/review: New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
- DOI 10.1177/0091270007312153
- S. M. Huang J. M. Strong L. Zhang K. S. Reynolds S. Nallani R. Temple S. Abraham S. A. Habet R. K. Baweja G. J. Burckart S. Chung P. Colangelo D. Frucht M. D. Green P. Hepp E. Karnaukhova H. S. Ko J. I. Lee P. J. Marroum J. M. Norden W. Qiu A. Rahman S. Sobel T. Stifano K. Thummel X. X. Wei S. Yasuda J. H. Zheng H. Zhao L. J. Lesko 2008 New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process J. Clin. Pharmacol. 48 662 670 18378963 1:CAS:528:DC%2BD1cXns1Kitr4%3D 10.1177/0091270007312153 (Pubitemid 351713150)
- (2008) Journal of Clinical Pharmacology , vol.48 , Issue.6 , pp. 662-670
- Huang, S.-M.¹ Strong, J.M.² Zhang, L.³ Reynolds, K.S.⁴ Nallani, S.⁵ Temple, R.⁶ Abraham, S.⁷ Al Habet, S.⁸ Baweja, R.K.⁹ Burckart, G.J.¹⁰ Chung, S.¹¹ Colangelo, P.¹² Frucht, D.¹³ Green, M.D.¹⁴ Hepp, P.¹⁵ Karnaukhova, E.¹⁶ Ko, H.-S.¹⁷ Lee, J.-I.¹⁸ Marroum, P.J.¹⁹ Norden, J.M.²⁰ more..

38
- 0036304016
- Pharmacokinetic interactions between herbal remedies and medicinal drugs
- DOI 10.1080/00498250210124147
- C. Ioannides 2002 Pharmacokinetic interactions between herbal remedies and medicinal drugs Xenobiotica 32 451 478 12160480 1:CAS:528: DC%2BD38XlsVCltr4%3D 10.1080/00498250210124147 (Pubitemid 34743619)
- (2002) Xenobiotica , vol.32 , Issue.6 , pp. 451-478
- Ioannides, C.¹

39
- 67650821911
- Quantitative analysis of UDP-glucuronosyl transferase (UGT) 1A and UGT2B expression levels in human livers
- 19439486 1:CAS:528:DC%2BD1MXps1ygtLk%3D 10.1124/dmd.109.027227
- T. Izukawa M. Nakajima R. Fujiwara H. Yamanaka T. Fukami M. Takamiya Y. Aoki S. Ikushiro T. Sakaki T. Yokoi 2009 Quantitative analysis of UDP-glucuronosyl transferase (UGT) 1A and UGT2B expression levels in human livers Drug Metab. Dispos. 37 1759 1768 19439486 1:CAS:528:DC%2BD1MXps1ygtLk%3D 10.1124/dmd.109.027227
- (2009) Drug Metab. Dispos. , vol.37 , pp. 1759-1768
- Izukawa, T.¹ Nakajima, M.² Fujiwara, R.³ Yamanaka, H.⁴ Fukami, T.⁵ Takamiya, M.⁶ Aoki, Y.⁷ Ikushiro, S.⁸ Sakaki, T.⁹ Yokoi, T.¹⁰

40
- 69749095454
- Interactions between herbal medicines and prescribed drugs: An updated systematic review
- 19719333 1:CAS:528:DC%2BD1MXhtlehtbbF 10.2165/11317010-000000000-00000
- A. A. Izzo E. Ernst 2009 Interactions between herbal medicines and prescribed drugs: an updated systematic review Drugs 69 1777 1798 19719333 1:CAS:528:DC%2BD1MXhtlehtbbF 10.2165/11317010-000000000-00000
- (2009) Drugs , vol.69 , pp. 1777-1798
- Izzo, A.A.¹ Ernst, E.²

41
- 15244342411
- UDP-glucuronosyltransferases and clinical drug-drug interactions
- DOI 10.1016/j.pharmthera.2004.10.013
- T. K. Kiang M. H. Ensom T. K. Chang 2005 UDP-glucuronosyltransferases and clinical drug-drug interactions Pharmacol. Ther. 106 97 132 15781124 1:CAS:528:DC%2BD2MXisFGlsLk%3D 10.1016/j.pharmthera.2004.10.013 (Pubitemid 40386722)
- (2005) Pharmacology and Therapeutics , vol.106 , Issue.1 , pp. 97-132
- Kiang, T.K.L.¹ Ensom, M.H.H.² Chang, T.K.H.³

42
- 79954486652
- In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes
- 21294626 1:CAS:528:DC%2BC3MXks1Wnsrw%3D 10.3109/00498254.2010.549968
- D. K. Kim K. H. Liu J. H. Jeong H. Y. Ji S. R. Oh H. K. Lee H. S. Lee 2011 In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes Xenobiotica 41 358 371 21294626 1:CAS:528:DC%2BC3MXks1Wnsrw%3D 10.3109/00498254.2010.549968
- (2011) Xenobiotica , vol.41 , pp. 358-371
- Kim, D.K.¹ Liu, K.H.² Jeong, J.H.³ Ji, H.Y.⁴ Oh, S.R.⁵ Lee, H.K.⁶ Lee, H.S.⁷

43
- 25144525190
- High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry
- DOI 10.1002/rcm.2110
- M. J. Kim H. Kim I. J. Cha J. S. Park J. H. Shon K. H. Liu J. G. Shin 2005 High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry Rapid Commun. Mass Spectrom. 19 2651 2658 16124035 1:CAS:528:DC%2BD2MXhtVKntr%2FJ 10.1002/rcm.2110 (Pubitemid 41338608)
- (2005) Rapid Communications in Mass Spectrometry , vol.19 , Issue.18 , pp. 2651-2658
- Kim, M.-J.¹ Kim, H.² Cha, I.-J.³ Park, J.-S.⁴ Shon, J.-H.⁵ Liu, K.-H.⁶ Shin, J.-G.⁷

44
- 42449095963
- Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans
- DOI 10.1124/dmd.107.019539
- S. Klieber S. Hugla R. Ngo C. Arabeyre-Fabre V. Meunier F. Sadoun O. Fedeli M. Rival M. Bourrie F. Guillou P. Maurel G. Fabre 2008 Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans Drug Metab. Dispos. 36 851 862 18256203 1:CAS:528: DC%2BD1cXltlWktbs%3D 10.1124/dmd.107.019539 (Pubitemid 351574882)
- (2008) Drug Metabolism and Disposition , vol.36 , Issue.5 , pp. 851-862
- Klieber, S.¹ Hugla, S.² Ngo, R.³ Arabeyre-Fabre, C.⁴ Meunier, V.⁵ Sadoun, F.⁶ Fedeli, O.⁷ Rival, M.⁸ Bourrie, M.⁹ Guillou, F.¹⁰ Maurel, P.¹¹ Fabre, G.¹²

45
- 34547946590
- In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes
- DOI 10.1080/00498250701534877, PII 781353247
- H. S. Lee H. Y. Ji E. J. Park S. Y. Kim 2007 In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes Xenobiotica 37 803 817 17701830 1:CAS:528:DC%2BD2sXptVGnu7c%3D 10.1080/00498250701534877 (Pubitemid 47267806)
- (2007) Xenobiotica , vol.37 , Issue.8 , pp. 803-817
- Lee, H.S.¹ Ji, H.Y.² Park, E.J.³ Kim, S.Y.⁴

46
- 61449220882
- Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways
- 19034627 1:CAS:528:DC%2BD1cXhsVaisbjP 10.1007/s11095-008-9788-8
- L. Li J. D. Stanton A. H. Tolson Y. Luo H. Wang 2009 Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways Pharm. Res. 26 872 882 19034627 1:CAS:528:DC%2BD1cXhsVaisbjP 10.1007/s11095-008-9788-8
- (2009) Pharm. Res. , vol.26 , pp. 872-882
- Li, L.¹ Stanton, J.D.² Tolson, A.H.³ Luo, Y.⁴ Wang, H.⁵

47
- 0036890353
- Complexities of glucuronidation affecting in vitro-in vivo extrapolation
- DOI 10.2174/1389200023336992
- J. H. Lin B. K. Wong 2002 Complexities of glucuronidation affecting in vitro in vivo extrapolation Curr. Drug Metab. 3 623 646 12369890 1:CAS:528:DC%2BD38XoslKiu7Y%3D 10.2174/1389200023336992 (Pubitemid 35331663)
- (2002) Current Drug Metabolism , vol.3 , Issue.6 , pp. 623-646
- Lin, J.H.¹ Wong, B.K.²

48
- 33745395225
- CYP induction-mediated drug interactions: In vitro assessment and clinical implications
- DOI 10.1007/s11095-006-0277-7
- J. H. Lin 2006 CYP induction-mediated drug interactions: in vitro assessment and clinical implications Pharm. Res. 23 1089 1116 16718615 1:CAS:528:DC%2BD28XmtFCnsbc%3D 10.1007/s11095-006-0277-7 (Pubitemid 43946134)
- (2006) Pharmaceutical Research , vol.23 , Issue.6 , pp. 1089-1116
- Lin, J.H.¹

49
- 33644822200
- Hyperforin in St. John's wort drug interactions
- DOI 10.1007/s00228-006-0096-0
- R. Madabushi B. Frank B. Drewelow H. Derendorf V. Butterweck 2006 Hyperforin in St. John's wort drug interactions Eur. J. Clin. Pharmacol. 62 225 233 16477470 1:CAS:528:DC%2BD28XitFOgs7o%3D 10.1007/s00228-006-0096-0 (Pubitemid 43357581)
- (2006) European Journal of Clinical Pharmacology , vol.62 , Issue.3 , pp. 225-233
- Madabushi, R.¹ Frank, B.² Drewelow, B.³ Derendorf, H.⁴ Butterweck, V.⁵

50
- 0035126841
- Global harmonization of herbal health claims
- G. B. Mahady 2001 Global harmonization of herbal health claims J. Nutr. 131 1120s 1123s 11238830 1:CAS:528:DC%2BD3MXhvVOhs74%3D (Pubitemid 32195021)
- (2001) Journal of Nutrition , vol.131 , Issue.3
- Mahady, G.B.¹

51
- 0033787159
- Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin
- 11073292 1:STN:280:DC%2BD3crhsVensg%3D%3D
- I. Mai H. Krüger K. Budde A. Johne J. Brockmöller H. H. Neumayer I. Roots 2000 Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin Int. J. Clin. Pharmacol. Ther. 38 500 502 11073292 1:STN:280:DC%2BD3crhsVensg%3D%3D
- (2000) Int. J. Clin. Pharmacol. Ther. , vol.38 , pp. 500-502
- Mai, I.¹ Krüger, H.² Budde, K.³ Johne, A.⁴ Brockmöller, J.⁵ Neumayer, H.H.⁶ Roots, I.⁷

52
- 4744359869
- Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction
- DOI 10.1016/j.clpt.2004.07.004, PII S000992360400236X
- I. Mai S. Bauer E. S. Perloff A. Johne B. Uehleke B. Frank K. Budde I. Roots 2004 Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction Clin. Pharmacol. Ther. 76 330 340 15470332 1:CAS:528:DC%2BD2cXotlCmtLk%3D 10.1016/j.clpt.2004.07.004 (Pubitemid 39313123)
- (2004) Clinical Pharmacology and Therapeutics , vol.76 , Issue.4 , pp. 330-340
- Mai, I.¹ Bauer, S.² Perloff, E.S.³ Johne, A.⁴ Uehleke, B.⁵ Frank, B.⁶ Budde, K.⁷ Roots, I.⁸

53
- 4544235407
- Drug interactions with St John's Wort: Mechanisms and clinical implications
- DOI 10.2165/00002018-200427110-00003
- M. Mannel 2004 Drug interactions with St John's wort: mechanisms and clinical implications Drug Saf. 27 773 797 15350151 1:CAS:528: DC%2BD2cXosl2gsLc%3D 10.2165/00002018-200427110-00003 (Pubitemid 39243561)
- (2004) Drug Safety , vol.27 , Issue.11 , pp. 773-797
- Mannel, M.¹

54
- 0344464750
- Multiple-Dose Administration of Ginkgo biloba Did Not Affect Cytochrome P-450 2D6 or 3A4 Activity in Normal Volunteers
- DOI 10.1097/01.jcp.0000095340.32154.c6
- J. S. Markowitz J. L. Donovan C. Lindsay DeVane L. Sipkes K. D. Chavin 2003 Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers J. Clin. Psychopharmacol. 23 576 581 14624188 1:CAS:528:DC%2BD3sXptVCntLg%3D 10.1097/01.jcp.0000095340.32154.c6 (Pubitemid 37443189)
- (2003) Journal of Clinical Psychopharmacology , vol.23 , Issue.6 , pp. 576-581
- Markowitz, J.S.¹ Donovan, J.L.² DeVane, C.L.³ Sipkes, L.⁴ Chavin, K.D.⁵

55
- 33746047547
- Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes
- DOI 10.1124/dmd.106.009969
- D. F. McGinnity A. J. Berry J. R. Kenny K. Grime R. J. Riley 2006 Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes Drug Metab. Dispos. 34 1291 1300 16679385 1:CAS:528: DC%2BD28Xnslaktbk%3D 10.1124/dmd.106.009969 (Pubitemid 44079869)
- (2006) Drug Metabolism and Disposition , vol.34 , Issue.8 , pp. 1291-1300
- McGinnity, D.F.¹ Berry, A.J.² Kenny, J.R.³ Grime, K.⁴ Riley, R.J.⁵

56
- 3042802316
- Interaction of St John's wort with conventional drugs: Systematic review of clinical trials
- E. Mills V. M. Montori P. Wu K. Gallicano M. Clarke G. Guyatt 2004 Interaction of St John's wort with conventional drugs: systematic review of clinical trials BMJ 329 27 30 15231618 10.1136/bmj.329.7456.27 (Pubitemid 38869998)
- (2004) British Medical Journal , vol.329 , Issue.7456 , pp. 27-30
- Mills, E.¹ Montori, V.M.² Wu, P.³ Gallicano, K.⁴ Clarke, M.⁵ Guyatt, G.⁶

57
- 1642273510
- Induction of Drug Metabolism Enzymes and MDR1 Using a Novel Human Hepatocyte Cell Line
- DOI 10.1124/jpet.103.061713
- J. B. Mills K. A. Rose N. Sadagopan J. Sahi S. M. de Morais 2004 Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line J. Pharmacol. Exp. Ther. 309 303 309 14722322 1:CAS:528: DC%2BD2cXivFamtbs%3D 10.1124/jpet.103.061713 (Pubitemid 38393143)
- (2004) Journal of Pharmacology and Experimental Therapeutics , vol.309 , Issue.1 , pp. 303-309
- Mills, J.B.¹ Rose, K.A.² Sadagopan, N.³ Sahi, J.⁴ De Morais, S.M.F.⁵

58
- 34250156690
- Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content
- DOI 10.1211/jpp.59.4.0012
- M. Modarai J. Gertsch A. Suter M. Heinrich A. Kortenkamp 2007 Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content J. Pharm. Pharmacol. 59 567 573 17430641 1:CAS:528:DC%2BD2sXktVOiu70%3D 10.1211/jpp.59.4.0012 (Pubitemid 47051131)
- (2007) Journal of Pharmacy and Pharmacology , vol.59 , Issue.4 , pp. 567-573
- Modarai, M.¹ Gertsch, J.² Suter, A.³ Heinrich, M.⁴ Kortenkamp, A.⁵

59
- 79952479196
- Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies
- 21049395 1:CAS:528:DC%2BC3MXkvVOmsr4%3D 10.1055/s-0030-1250457
- M. E. Mohamed R. F. Frye 2011 Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies Planta Med. 77 311 321 21049395 1:CAS:528:DC%2BC3MXkvVOmsr4%3D 10.1055/s-0030-1250457
- (2011) Planta Med. , vol.77 , pp. 311-321
- Mohamed, M.E.¹ Frye, R.F.²

60
- 31544472883
- Ginkgo biloba: Evaluation of CYP2C9 drug interactions in vitro and in vivo
- DOI 10.1097/01.mjt.0000143695.68285.31
- M. A. Mohutsky G. D. Anderson J. W. Miller G. W. Elmer 2006 Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am. J. Ther. 13 24 31 16428919 10.1097/01.mjt.0000143695.68285.31 (Pubitemid 43162445)
- (2006) American Journal of Therapeutics , vol.13 , Issue.1 , pp. 24-31
- Mohutsky, M.A.¹ Anderson, G.D.² Miller, J.W.³ Elmer, G.W.⁴

61
- 78751538834
- Metabolism study of botanical drugs
- 21191750 1:CAS:528:DC%2BC3cXhs1aksbfJ 10.1007/s12272-010-1200-7
- D. H. Na 2010 Metabolism study of botanical drugs Arch. Pharm. Res. 33 1877 1879 21191750 1:CAS:528:DC%2BC3cXhs1aksbfJ 10.1007/s12272-010-1200-7
- (2010) Arch. Pharm. Res. , vol.33 , pp. 1877-1879
- Na, D.H.¹

62
- 0036266825
- Imipramine N-glucuronidation in human liver microsomes: Biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms
- DOI 10.1124/dmd.30.6.636
- M. Nakajima E. Tanaka T. Kobayashi N. Ohashi T. Kume T. Yokoi 2002 Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms Drug Metab. Dispos. 30 636 642 12019188 1:CAS:528:DC%2BD38XktFSlsLY%3D 10.1124/dmd.30.6.636 (Pubitemid 34579095)
- (2002) Drug Metabolism and Disposition , vol.30 , Issue.6 , pp. 636-642
- Nakajima, M.¹ Tanaka, E.² Kobayashi, T.³ Ohashi, N.⁴ Kume, T.⁵ Yokoi, T.⁶

63
- 33748886662
- Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone
- DOI 10.1016/j.abb.2006.07.010, PII S0003986106002608
- T. Nishiyama T. Kobori K. Arai K. Ogura T. Ohnuma K. Ishii K. Hayashi A. Hiratsuka 2006 Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone Arch. Biochem. Biophys. 454 72 79 16949544 1:CAS:528:DC%2BD28XhtVagu77N 10.1016/j.abb.2006.07.010 (Pubitemid 44427739)
- (2006) Archives of Biochemistry and Biophysics , vol.454 , Issue.1 , pp. 72-79
- Nishiyama, T.¹ Kobori, T.² Arai, K.³ Ogura, K.⁴ Ohnuma, T.⁵ Ishii, K.⁶ Hayashi, K.⁷ Hiratsuka, A.⁸

64
- 33846449874
- Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
- DOI 10.1124/dmd.106.012633
- R. S. Obach R. L. Walsky K. Venkatakrishnan 2007 Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions Drug Metab. Dispos. 35 246 255 17093004 1:CAS:528: DC%2BD2sXhvVKrs7k%3D 10.1124/dmd.106.012633 (Pubitemid 46148737)
- (2007) Drug Metabolism and Disposition , vol.35 , Issue.2 , pp. 246-255
- Obach, R.S.¹ Walsky, R.L.² Venkatakrishnan, K.³

65
- 2142768709
- Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats
- N. Ohnishi M. Kusuhara M. Yoshioka K. Kuroda A. Soga F. Nishikawa T. Koishi M. Nakagawa S. Hori T. Matsumoto M. Yamashita S. Ohta K. Takara T. Yokoyama 2003 Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats Biol. Pharm. Bull. 26 1315 1320 12951478 1:CAS:528:DC%2BD3sXnsVGktrk%3D 10.1248/bpb.26.1315 (Pubitemid 41656569)
- (2003) Biological and Pharmaceutical Bulletin , vol.26 , Issue.9 , pp. 1315-1320
- Ohnishi, N.¹ Kusuhara, M.² Yoshioka, M.³ Kuroda, K.⁴ Soga, A.⁵ Nishikawa, F.⁶ Koishi, T.⁷ Nakagawa, M.⁸ Hori, S.⁹ Matsumoto, T.¹⁰ Yamashita, M.¹¹ Ohta, S.¹² Takara, K.¹³ Yokoyama, T.¹⁴

66
- 58149467072
- Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by realtime reverse transcriptase-polymerase chain reaction
- 18838504 1:CAS:528:DC%2BD1MXhsVSnuw%3D%3D 10.1124/dmd.108.023598
- S. Ohno S. Nakajin 2009 Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by realtime reverse transcriptase-polymerase chain reaction Drug Metab. Dispos. 37 32 40 18838504 1:CAS:528:DC%2BD1MXhsVSnuw%3D%3D 10.1124/dmd.108. 023598
- (2009) Drug Metab. Dispos. , vol.37 , pp. 32-40
- Ohno, S.¹ Nakajin, S.²

67
- 79551633386
- An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS
- 21198441 1:CAS:528:DC%2BC3MXhs1Ckt7c%3D 10.2174/187231211794455235
- J. N. Otten G. P. Hingorani D. P. Hartley S. D. Kragerud R. B. Franklin 2011 An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS Drug Metab. Lett. 5 17 24 21198441 1:CAS:528:DC%2BC3MXhs1Ckt7c%3D 10.2174/187231211794455235
- (2011) Drug Metab. Lett. , vol.5 , pp. 17-24
- Otten, J.N.¹ Hingorani, G.P.² Hartley, D.P.³ Kragerud, S.D.⁴ Franklin, R.B.⁵

68
- 33644891064
- MDR- and CYP3A4-mediated drugherbal interactions
- 16442130 1:CAS:528:DC%2BD28XisF2qsbs%3D 10.1016/j.lfs.2005.12.010
- D. Pal A. K. Mitra 2006 MDR- and CYP3A4-mediated drugherbal interactions Life Sci. 78 2131 2145 16442130 1:CAS:528:DC%2BD28XisF2qsbs%3D 10.1016/j.lfs.2005.12.010
- (2006) Life Sci. , vol.78 , pp. 2131-2145
- Pal, D.¹ Mitra, A.K.²

69
- 77949285974
- System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome p450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: Human hepatocytes versus liver microsomes versus recombinant enzymes
- 20208386 1:CAS:528:DC%2BC3cXlsVSmurw%3D 10.2133/dmpk.25.16
- A. Parkinson F. Kazmi D. B. Buckley P. Yerino B. W. Ogilvie B. L. Paris 2010 System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome p450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes Drug Metab. Pharmacokinet. 25 16 27 20208386 1:CAS:528:DC%2BC3cXlsVSmurw%3D 10.2133/dmpk.25.16
- (2010) Drug Metab. Pharmacokinet. , vol.25 , pp. 16-27
- Parkinson, A.¹ Kazmi, F.² Buckley, D.B.³ Yerino, P.⁴ Ogilvie, B.W.⁵ Paris, B.L.⁶

70
- 77954295707
- Natural products drug discovery: Accelerating the clinical candidate development using reverse pharmacology approaches
- 21046974 1:CAS:528:DC%2BC3cXlsVWntrk%3D
- B. Patwardhan A. D. Vaidya 2010 Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches Indian J. Exp. Biol. 48 220 227 21046974 1:CAS:528: DC%2BC3cXlsVWntrk%3D
- (2010) Indian J. Exp. Biol. , vol.48 , pp. 220-227
- Patwardhan, B.¹ Vaidya, A.D.²

71
- 0344938358
- Inhibition and induction of human cytochrome P450 (CYP) enzymes
- DOI 10.1080/004982598238886
- O. Pelkonen J. Mäenpää P. Taavitsainen A. Rautio H. Raunio 1998 Inhibition and induction of human cytochrome P450 (CYP) enzymes Xenobiotica 28 1203 1253 9890159 1:CAS:528:DyaK1MXktFWlsg%3D%3D 10.1080/004982598238886 (Pubitemid 29017141)
- (1998) Xenobiotica , vol.28 , Issue.12 , pp. 1203-1253
- Pelkonen, O.¹ Maenpaaj, J.² Taavitsainen, P.³ Rautio, A.⁴ Raunio, H.⁵

72
- 55049100842
- Inhibition and induction of human cytochrome P450 enzymes: Current status
- 18618097 1:CAS:528:DC%2BD1cXht1ehtLfL 10.1007/s00204-008-0332-8
- O. Pelkonen M. Turpeinen J. Hakkola P. Honkakoski J. Hukkanen H. Raunio 2008 Inhibition and induction of human cytochrome P450 enzymes: current status Arch. Toxicol. 82 667 715 18618097 1:CAS:528:DC%2BD1cXht1ehtLfL 10.1007/s00204-008-0332-8
- (2008) Arch. Toxicol. , vol.82 , pp. 667-715
- Pelkonen, O.¹ Turpeinen, M.² Hakkola, J.³ Honkakoski, P.⁴ Hukkanen, J.⁵ Raunio, H.⁶

73
- 34548283499
- In vitro approaches to investigate mechanism-based inactivation of CYP enzymes
- DOI 10.1517/17425255.3.3.321
- T. M. Polasek J. O. Miners 2007 In vitro approaches to investigate mechanism-based inactivation of CYP enzymes Expert Opin. Drug Metab. Toxicol. 3 321 329 17539741 1:CAS:528:DC%2BD2sXlvFaktrY%3D 10.1517/17425255.3.3.321 (Pubitemid 47316027)
- (2007) Expert Opinion on Drug Metabolism and Toxicology , vol.3 , Issue.3 , pp. 321-329
- Polasek, T.M.¹ Miners, J.O.²

74
- 21844435507
- Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics
- DOI 10.1016/j.clpt.2005.01.024, PII S0009923605001670
- J. Rengelshausen M. Banfield K. D. Riedel J. Burhenne J. Weiss T. Thomsen I. Walter-Sack W. E. Haefeli G. Mikus 2005 Opposite effects of short-term and longterm St. John's wort intake on voriconazole pharmacokinetics Clin. Pharmacol. Ther. 78 25 33 16003289 1:CAS:528:DC%2BD2MXlvFKruro%3D 10.1016/j.clpt.2005.01.024 (Pubitemid 40956928)
- (2005) Clinical Pharmacology and Therapeutics , vol.78 , Issue.1 , pp. 25-33
- Rengelshausen, J.¹ Banfield, M.² Riedel, K.-D.³ Burhenne, J.⁴ Weiss, J.⁵ Thomsen, T.⁶ Walter-Sack, I.⁷ Haefeli, W.E.⁸ Mikus, G.⁹

75
- 39749122043
- Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects
- DOI 10.1185/030079908X260871
- S. M. Robertson R. T. Davey J. Voell E. Formentini R. M. Alfaro S. R. Penzak 2008 Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects Curr. Med. Res. Opin. 24 591 599 18205997 1:CAS:528:DC%2BD1cXktlahs7c%3D 10.1185/030079908X260871 (Pubitemid 351294409)
- (2008) Current Medical Research and Opinion , vol.24 , Issue.2 , pp. 591-599
- Robertson, S.M.¹ Davey, R.T.² Voell, J.³ Formentini, E.⁴ Alfaro, R.M.⁵ Penzak, S.R.⁶

76
- 0027931806
- Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus
- J. Sahai K. Gallicano A. Pakuts D. W. Cameron 1994 Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus J. Infect. Dis. 169 1103 1107 8169401 1:STN:280:DyaK2c3itlSksA%3D%3D 10.1093/infdis/169.5.1103 (Pubitemid 24303236)
- (1994) Journal of Infectious Diseases , vol.169 , Issue.5 , pp. 1103-1107
- Sahai, J.¹ Gallicano, K.² Pakuts, A.³ Cameron, D.W.⁴

77
- 34247244726
- Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol
- DOI 10.1038/sj.clpt.6100191, PII 6100191
- U. I. Schwarz H. Hanso R. Oertel S. Miehlke E. Kuhlisch H. Glaeser M. Hitzl G. K. Dresser R. B. Kim W. Kirch 2007 Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol Clin. Pharmacol. Ther. 81 669 678 17392718 1:CAS:528:DC%2BD2sXlsFCqsL0%3D 10.1038/sj.clpt.6100191 (Pubitemid 46625125)
- (2007) Clinical Pharmacology and Therapeutics , vol.81 , Issue.5 , pp. 669-678
- Schwarz, U.I.¹ Hanso, H.² Oertel, R.³ Miehlke, S.⁴ Kuhlisch, E.⁵ Glaeser, H.⁶ Hitzl, M.⁷ Dresser, G.K.⁸ Kim, R.B.⁹ Kirch, W.¹⁰

78
- 77949457681
- Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail
- 20218935 1:CAS:528:DC%2BC3cXjtVyhs74%3D 10.3109/00498251003592683
- D. K. Sevior J. Hokkanen A. Tolonen K. Abass L. Tursas O. Pelkonen J. T. Ahokas 2010 Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail Xenobiotica 40 245 254 20218935 1:CAS:528:DC%2BC3cXjtVyhs74%3D 10.3109/00498251003592683
- (2010) Xenobiotica , vol.40 , pp. 245-254
- Sevior, D.K.¹ Hokkanen, J.² Tolonen, A.³ Abass, K.⁴ Tursas, L.⁵ Pelkonen, O.⁶ Ahokas, J.T.⁷

79
- 70350023302
- Drug-botanical interactions: A review of the laboratory, animal, and human data for 8 common botanicals
- 19815591 1:CAS:528:DC%2BD1MXhtlagu73I
- S. S. Shord K. Shah A. Lukose 2009 Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals Integr. Cancer Ther. 8 208 227 19815591 1:CAS:528:DC%2BD1MXhtlagu73I
- (2009) Integr. Cancer Ther. , vol.8 , pp. 208-227
- Shord, S.S.¹ Shah, K.² Lukose, A.³

80
- 53849093733
- Current industrial practices in assessing CYP450 enzyme induction: Preclinical and clinical
- 18686044 1:CAS:528:DC%2BD1cXhtlOgsbjL 10.1208/s12248-008-9037-4
- M. Sinz G. Wallace J. Sahi 2008 Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical AAPS J. 10 391 400 18686044 1:CAS:528:DC%2BD1cXhtlOgsbjL 10.1208/s12248-008-9037-4
- (2008) AAPS J. , vol.10 , pp. 391-400
- Sinz, M.¹ Wallace, G.² Sahi, J.³

81
- 36549073316
- Drug interactions with herbal medicines
- DOI 10.1097/FTD.0b013e31815c17f6, PII 0000769120071200000001
- S. Skalli A. Zaid R. Soulaymani 2007 Drug interactions with herbal medicines Ther. Drug Monit. 29 679 686 18043467 1:CAS:528:DC%2BD2sXhtlGiu7fI 10.1097/FTD.0b013e31815c17f6 (Pubitemid 350190846)
- (2007) Therapeutic Drug Monitoring , vol.29 , Issue.6 , pp. 679-686
- Skalli, S.¹ Zaid, A.² Soulaymani, R.³

82
- 34247261031
- Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery
- DOI 10.1016/j.jchromb.2006.12.024, PII S1570023206010385
- D. Smith N. Sadagopan M. Zientek A. Reddy L. Cohen 2007 Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 850 455 463 17270503 1:CAS:528:DC%2BD2sXkslOjsr4%3D 10.1016/j.jchromb.2006.12. 024 (Pubitemid 46618196)
- (2007) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences , vol.850 , Issue.1-2 , pp. 455-463
- Smith, D.¹ Sadagopan, N.² Zientek, M.³ Reddy, A.⁴ Cohen, L.⁵

83
- 1642579667
- An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes
- DOI 10.1124/dmd.32.1.140
- M. G. Soars D. M. Petullo J. A. Eckstein S. C. Kasper S. A. Wrighton 2004 An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes Drug Metab. Dispos. 32 140 148 14709631 1:CAS:528: DC%2BD2cXnsFWqs7Y%3D 10.1124/dmd.32.1.140 (Pubitemid 38112546)
- (2004) Drug Metabolism and Disposition , vol.32 , Issue.1 , pp. 140-148
- Soars, M.G.¹ Petullo, D.M.² Eckstein, J.A.³ Kasper, S.C.⁴ Wrighton, S.A.⁵

84
- 78751546669
- In vitro metabolism of jaceosidin and characterization of cytochrome P450 and UDP-glucuronosyltransferase enzymes in human liver microsomes
- 21191764 1:CAS:528:DC%2BC3cXhs1aksbvF 10.1007/s12272-010-1214-1
- W. Y. Song H. Y. Ji N. I. Baek T. S. Jeong H. S. Lee 2010 In vitro metabolism of jaceosidin and characterization of cytochrome P450 and UDP-glucuronosyltransferase enzymes in human liver microsomes Arch. Pharm. Res. 33 1985 1996 21191764 1:CAS:528:DC%2BC3cXhs1aksbvF 10.1007/s12272-010-1214-1
- (2010) Arch. Pharm. Res. , vol.33 , pp. 1985-1996
- Song, W.Y.¹ Ji, H.Y.² Baek, N.I.³ Jeong, T.S.⁴ Lee, H.S.⁵

85
- 38949153147
- Biochemistry: Lifting the veil on traditional Chinese medicine
- DOI 10.1126/science.319.5864.709
- R. Stone 2008 Biochemistry. Lifting the veil on traditional Chinese medicine Science 319 709 710 18258866 1:CAS:528:DC%2BD1cXitVymtLo%3D 10.1126/science.319.5864.709 (Pubitemid 351225838)
- (2008) Science , vol.319 , Issue.5864 , pp. 709-710
- Stone, R.¹

86
- 35348982778
- Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats
- DOI 10.1016/j.fct.2007.05.023, PII S0278691507002104
- J. Tang J. Sun Y. Zhang L. Li F. Cui Z. He 2007 Herbdrug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats Food Chem. Toxicol. 45 2441 2445 17681658 1:CAS:528:DC%2BD2sXht1ahs77O 10.1016/j.fct.2007.05.023 (Pubitemid 47600451)
- (2007) Food and Chemical Toxicology , vol.45 , Issue.12 , pp. 2441-2445
- Tang, J.¹ Sun, J.² Zhang, Y.³ Li, L.⁴ Cui, F.⁵ He, Z.⁶

87
- 0037212558
- High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry
- DOI 10.1016/S0731-7085(02)00480-6, PII S0731708502004806
- S. A. Testino Jr. G. Patonay 2003 High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatographytandem mass spectrometry J. Pharm. Biomed. Anal. 30 1459 1467 12467917 1:CAS:528:DC%2BD38XptFKhsLw%3D 10.1016/S0731-7085(02)00480-6 (Pubitemid 35435339)
- (2003) Journal of Pharmaceutical and Biomedical Analysis , vol.30 , Issue.5 , pp. 1459-1467
- Testino Jr., S.A.¹ Patonay, G.²

88
- 34447343085
- In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: Analytical validation and testing with monoclonal anti-CYP antibodies
- DOI 10.1002/jms.1239
- A. Tolonen A. Petsalo M. Turpeinen J. Uusitalo O. Pelkonen 2007 In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies J. Mass Spectrom. 42 960 966 17565714 1:CAS:528:DC%2BD2sXot1elurw%3D 10.1002/jms.1239 (Pubitemid 47057078)
- (2007) Journal of Mass Spectrometry , vol.42 , Issue.7 , pp. 960-966
- Tolonen, A.¹ Petsalo, A.² Turpeinen, M.³ Uusitalo, J.⁴ Pelkonen, O.⁵

89
- 33749838677
- Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers
- DOI 10.1177/0091270006292628
- S. Uchida H. Yamada X. D. Li S. Maruyama Y. Ohmori T. Oki H. Watanabe K. Umegaki K. Ohashi S. Yamada 2006 Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers J. Clin. Pharmacol. 46 1290 1298 17050793 1:CAS:528: DC%2BD28Xht1WjsbzE 10.1177/0091270006292628 (Pubitemid 44564357)
- (2006) Journal of Clinical Pharmacology , vol.46 , Issue.11 , pp. 1290-1298
- Uchida, S.¹ Yamada, H.² Xiao, D.L.³ Maruyama, S.⁴ Ohmori, Y.⁵ Oki, T.⁶ Watanabe, H.⁷ Umegaki, K.⁸ Ohashi, K.⁹ Yamada, S.¹⁰

90
- 33644929029
- In vitro and in vivo assessment of herb drug interactions
- 16427092 1:CAS:528:DC%2BD28XisF2qsb8%3D 10.1016/j.lfs.2005.12.021
- R. Venkataramanan B. Komoroski S. Strom 2006 In vitro and in vivo assessment of herb drug interactions Life Sci. 78 2105 2115 16427092 1:CAS:528:DC%2BD28XisF2qsb8%3D 10.1016/j.lfs.2005.12.021
- (2006) Life Sci. , vol.78 , pp. 2105-2115
- Venkataramanan, R.¹ Komoroski, B.² Strom, S.³

91
- 0037404036
- Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1
- DOI 10.1124/dmd.31.5.589
- Y. Watanabe M. Nakajima N. Ohashi T. Kume T. Yokoi 2003 Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1 Drug Metab. Dispos. 31 589 595 12695347 1:CAS:528:DC%2BD3sXjt1Ggt7g%3D 10.1124/dmd.31.5.589 (Pubitemid 36444168)
- (2003) Drug Metabolism and Disposition , vol.31 , Issue.5 , pp. 589-595
- Watanabe, Y.¹ Nakajima, M.² Ohashi, N.³ Kume, T.⁴ Yokoi, T.⁵

92
- 77950278582
- Effects of Ginkgo biloba in dementia: Systematic review and meta-analysis
- 20236541 10.1186/1471-2318-10-14
- S. Weinmann S. Roll C. Schwarzbach C. Vauth S. N. Willich 2010 Effects of Ginkgo biloba in dementia: systematic review and meta-analysis BMC Geriatr. 10 14 20236541 10.1186/1471-2318-10-14
- (2010) BMC Geriatr. , vol.10 , pp. 14
- Weinmann, S.¹ Roll, S.² Schwarzbach, C.³ Vauth, C.⁴ Willich, S.N.⁵

93
- 6944221357
- 1/AUC) ratios
- DOI 10.1124/dmd.104.000794
- J. A. Williams R. Hyland B. C. Jones D. A. Smith S. Hurst T. C. Goosen V. Peterkin J. R. Koup S. E. Ball 2004 Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios Drug Metab. Dispos. 32 1201 1208 15304429 1:CAS:528:DC%2BD2cXovFCktLg%3D 10.1124/dmd.104.000794 (Pubitemid 39410902)
- (2004) Drug Metabolism and Disposition , vol.32 , Issue.11 , pp. 1201-1208
- Williams, J.A.¹ Hyland, R.² Jones, B.C.³ Smith, D.A.⁴ Hurst, S.⁵ Goosen, T.C.⁶ Peterkin, V.⁷ Koup, J.R.⁸ Ball, S.E.⁹

94
- 77953528461
- Herbal interactions with anticancer drugs: Mechanistic and clinical considerations
- 20345351 1:CAS:528:DC%2BC3cXmvFCntb8%3D 10.2174/092986710791111279
- A. K. Yang S. M. He L. Liu J. P. Liu M. Q. Wei S. F. Zhou 2010 Herbal interactions with anticancer drugs: mechanistic and clinical considerations Curr. Med. Chem. 17 1635 1678 20345351 1:CAS:528:DC%2BC3cXmvFCntb8%3D 10.2174/092986710791111279
- (2010) Curr. Med. Chem. , vol.17 , pp. 1635-1678
- Yang, A.K.¹ He, S.M.² Liu, L.³ Liu, J.P.⁴ Wei, M.Q.⁵ Zhou, S.F.⁶

95
- 11144232127
- Pharmacogenetics and herb-drug interactions: Experience with Ginkgo biloba and omeprazole
- DOI 10.1097/00008571-200412000-00007
- O. Q. Yin B. Tomlinson M. M. Waye A. H. Chow M. S. Chow 2004 Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole Pharmacogenetics 14 841 850 15608563 10.1097/00008571-200412000-00007 (Pubitemid 40054339)
- (2004) Pharmacogenetics , vol.14 , Issue.12 , pp. 841-850
- Yin, O.Q.P.¹ Tomlinson, B.² Waye, M.M.Y.³ Chow, A.H.L.⁴ Chow, M.S.S.⁵

96
- 21644431702
- Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats
- DOI 10.1248/bpb.27.2042
- M. Yoshioka N. Ohnishi N. Sone S. Egami K. Takara T. Yokoyama K. Kuroda 2004 Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats Biol. Pharm. Bull. 27 2042 2045 15577230 1:CAS:528:DC%2BD2MXptFGisg%3D%3D 10.1248/bpb.27.2042 (Pubitemid 41701588)
- (2004) Biological and Pharmaceutical Bulletin , vol.27 , Issue.12 , pp. 2042-2045
- Yoshioka, M.¹ Ohnishi, N.² Sone, N.³ Egami, S.⁴ Takara, K.⁵ Yokoyama, T.⁶ Kuroda, K.⁷

97
- 21644486138
- Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of Ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers
- DOI 10.1248/bpb.27.2006
- M. Yoshioka N. Ohnishi T. Koishi Y. Obata M. Nakagawa T. Matsumoto K. Tagagi K. Takara T. Ohkuni T. Yokoyama K. Kuroda 2004 Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers Biol. Pharm. Bull. 27 2006 2009 15577221 1:CAS:528:DC%2BD2MXptFGjsw%3D%3D 10.1248/bpb.27.2006 (Pubitemid 41701579)
- (2004) Biological and Pharmaceutical Bulletin , vol.27 , Issue.12 , pp. 2006-2009
- Yoshioka, M.¹ Ohnishi, N.² Koishi, T.³ Obata, Y.⁴ Nakagawa, M.⁵ Matsumoto, T.⁶ Tagagi, K.⁷ Takara, K.⁸ Ohkuni, T.⁹ Yokoyama, T.¹⁰ Kuroda, K.¹¹

98
- 78049445726
- Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis/LC-MS/MS
- 20642444 1:CAS:528:DC%2BC3cXhtVejur3F 10.2174/187231210791698483
- S. Zambon S. Fontana M. Kajbaf 2010 Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis/LC-MS/MS Drug Metab. Lett. 4 120 128 20642444 1:CAS:528:DC%2BC3cXhtVejur3F 10.2174/187231210791698483
- (2010) Drug Metab. Lett. , vol.4 , pp. 120-128
- Zambon, S.¹ Fontana, S.² Kajbaf, M.³

99
- 18844445670
- Evaluation of time-dependent inactivation of CYP3A in cryopreserved human hepatocytes
- DOI 10.1124/dmd.104.002832
- P. Zhao K. L. Kunze C. A. Lee 2005 Evaluation of timedependent inactivation of CYP3A in cryopreserved human hepatocytes Drug Metab. Dispos. 33 853 861 15743977 1:CAS:528:DC%2BD2MXksleks7g%3D 10.1124/dmd.104.002832 (Pubitemid 40686640)
- (2005) Drug Metabolism and Disposition , vol.33 , Issue.6 , pp. 853-861
- Zhao, P.¹ Kunze, K.L.² Lee, C.A.³

100
- 78049358974
- Bilirubin glucuronidation revisited: Proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1
- 20668247 1:CAS:528:DC%2BC3cXhsVWqurrM 10.1124/dmd.110.033829
- J. Zhou T. S. Tracy R. P. Remmel 2010 Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1 Drug Metab. Dispos. 38 1907 1911 20668247 1:CAS:528:DC%2BC3cXhsVWqurrM 10.1124/dmd.110.033829
- (2010) Drug Metab. Dispos. , vol.38 , pp. 1907-1911
- Zhou, J.¹ Tracy, T.S.² Remmel, R.P.³

101
- 0037286803
- Interactions of herbs with cytochrome P450
- DOI 10.1081/DMR-120018248
- S. Zhou Y. Gao W. Jiang M. Huang A. Xu J. W. Paxton 2003 Interaction of herbs with cytochrome P450 Drug Metab. Rev. 35 35 98 12635815 1:CAS:528:DC%2BD3sXit1Gqur0%3D 10.1081/DMR-120018248 (Pubitemid 36249785)
- (2003) Drug Metabolism Reviews , vol.35 , Issue.1 , pp. 35-98
- Zhou, S.¹ Gao, Y.² Jiang, W.³ Huang, M.⁴ Xu, A.⁵ Paxton, J.W.⁶

102
- 34547733497
- Identification of drugs that interact with herbs in drug development
- DOI 10.1016/j.drudis.2007.06.004, PII S1359644607002516
- S. F. Zhou Z. W. Zhou C. G. Li X. Chen X. Yu C. C. Xue A. Herington 2007 Identification of drugs that interact with herbs in drug development Drug Discov. Today 12 664 673 17706549 1:CAS:528:DC%2BD2sXpt1Snsbg%3D 10.1016/j.drudis.2007.06.004 (Pubitemid 47238642)
- (2007) Drug Discovery Today , vol.12 , Issue.15-16 , pp. 664-673
- Zhou, S.-F.¹ Zhou, Z.-W.² Li, C.-G.³ Chen, X.⁴ Yu, X.⁵ Xue, C.C.⁶ Herington, A.⁷

103
- 45249121177
- Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
- DOI 10.2174/138920008784220664
- S. F. Zhou 2008 Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4 Curr. Drug Metab. 9 310 322 18473749 1:CAS:528:DC%2BD1cXls1aitLY%3D 10.2174/138920008784220664 (Pubitemid 351836420)
- (2008) Current Drug Metabolism , vol.9 , Issue.4 , pp. 310-322
- Zhou, S.-F.¹

104
- 47349094025
- An update on clinical drug interactions with the herbal antidepressant St. John's wort
- DOI 10.2174/138920008784746391
- S. F. Zhou X. Lai 2008 An update on clinical drug interactions with the herbal antidepressant St. John's wort Curr. Drug Metab. 9 394 409 18537576 1:CAS:528:DC%2BD1cXotF2ntLs%3D 10.2174/138920008784746391 (Pubitemid 352025194)
- (2008) Current Drug Metabolism , vol.9 , Issue.5 , pp. 394-409
- Zhou, S.-F.¹ Lai, X.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.